Jim Tananbaum
VCFounder & CEO, Foresite Capital
Data-driven healthcare investor and serial founder
Background
Jim Tananbaum founded Foresite Capital in 2011, a healthcare-focused investment firm with approximately $3.5 billion in assets under management. He holds a BS and BSEE from Yale, an MD from Harvard (Harvard/MIT HST Program), and an MBA from Harvard. Earlier in his career he co-founded GelTex Pharmaceuticals, acquired by Sanofi-Genzyme for $1.4 billion, and co-founded Theravance Inc. He has been named to the Forbes Midas List five times and backed 10x Genomics, Jazz Pharmaceuticals, and Amerigroup.
Investment Thesis
Investments at the intersection of mathematics, algorithms, and biology to transform therapeutics, devices, diagnostics, and services.
Investment Focus
Stages
Sectors
Based in: San Francisco, CA (North America)